Advertisement
Advertisement

ILMN

ILMN logo

Illumina Inc

132.26
USD
Sponsored
+1.94
+1.49%
Apr 15, 16:00 UTC -4
Closed
exchange

After-Market

133.54

+1.28
+0.97%

Illumina Inc Profile

About

Illumina Inc. is a life sciences company, which provides tools and integrated systems for analysis of genetic variation and function. Using its proprietary technologies, the company provides innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, and gene expression profiling of DNA and RNA. Its customers include leading genomic research centers, academic institutions, government laboratories, hospitals and reference laboratories as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic and consumer genomics companies. Illumina generates revenue from two segments - Product and Service. Product are primarily attributed to the partnerships and collaborations to develop distributable clinical in-vitro diagnostics for Illumina sequencers. Service include genotyping and sequencing services as well as instrument maintenance contracts.

Info & Links

CEO

Jacob Thaysen

Headquarters

5200 ILLUMINA WAY
SAN DIEGO, CA 92122, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.illumina.com

Auditor

Ernst & Young LLP

Share holders

443

Employees

8,650

Illumina Inc Statistics

Valuation Measures

Market Capitalization2

20.29B

Enterprise Value

20.86B

Enterprise Value/EBITDA(ttm)

19.37

Price to Earnings Ratio(ttm)

25.50

Price to Sales(ttm)

4.35

Price to Book(mrq)

6.94

Price to Cash(ytd)

18.42

Profitability

Gross Margin(ttm)

66.09%

Operating Margin(ttm)

17.38%

Profit Margin(ttm)

19.36%

Return on Equity(ttm)

31.04%

Return on Invested Capital(ttm)

22.03%

Return on Assets(ttm)

12.04%

Income Statement

Revenue(ttm)

4.34B

Revenue Per Share(ttm)

28.40

Gross Profit(ttm)

2.87B

EBITDA(ttm)3

1.08B

Net Income Available to Common(ttm)

850.00M

Diluted EPS(ttm)

5.45

Share Statistics

Beta (5Y Monthly)

1.49

52-Week Change

76.21%

S&P 500 52-Week Change

33.12%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

152.90M

Dividend Yield

0.00%

Float4

148.93M

% Held by Insiders

2.60%

% Held by Institutions

89.42%

Balance Sheet

Total Cash(mrq)

1.63B

Total Cash Per Share(mrq)

10.68

Total Debt(mrq)

1.99B

Total Debt/Equity(mrq)

73.04%

Current Ratio(mrq)

2.08%

Quick Ratio(mrq)

1.72%

Book Value Per Share(mrq)

17.80

Cash Flow

Operating Cash Flow Per Share(ytd)

6.92

Free Cash Flow(ytd)

931.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement